Metformin Syncs CeO 2 to Recover Intra‐ and Extra‐Cellular ROS Homeostasis in Diabetic Wound Healing
Small · 2024-12 · 20 (52)
DOI: 10.1002/smll.202407802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 22.10.2024. Verfasst von Mengyang Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns and Cutaneous Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China. Hauptthemen laut MEDLINE: Metformin, Cerium, Wound Healing, Reactive Oxygen Species. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Key Project of the National Natural Science Foundation of China, General Program of the National Natural Science Foundation of China, Special Science Research Program for National Health and Public Welfare Industry in China.
Themen: Wundversorgung
Abstract (Originalsprache)
Excessive generation of reactive oxygen species (ROS) poses a huge obstacle to the healing process of diabetic wounds, resulting in chronic, non‐healing wounds. While numerous anti‐ROS therapeutics have been developed, satisfied intra‐ and extra‐ cellular ROS homeostasis is hard to be established in diabetic wounds. To address this issue, a nanoparticle via loading metformin and CeO 2 into mesoporous silica (MSN@Met‐CeO 2 ) is designed and synthesized, which is then encapsulated within ROS‐responsive hydrogel and shaped as microneedles (MNs) for better application in diabetic wounds. Interestingly, a unique metformin‐cerium chelate (Ce· 3Metformin) is formed during the synthesis of MSN@Met‐CeO 2 MN, which significantly strengthened the inhibitory effect of metformin on mitochondrial complex I. With the presence of Ce· 3Metformin, MSN@Met‐CeO 2 MN performed a remarkable effect on intracellular mtROS reduction as well as extracellular ROS elimination, the latter is primarily accomplished through the dissociative CeO 2 in MSN@Met‐CeO 2 MN. In the mouse diabetic wound model, MSN@Met‐CeO 2 MN exhibited a superior pro‐healing effect with accelerated inflammation resolution and enhanced angiogenesis, thus highlighting its significant potential for clinical application
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Burns and Cutaneous Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
- Department of Health Service, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
- Department of Plastic Surgery, Burns and Cosmetology, The First Affiliated Hospital of Xi'an Medical University, Xi'an, 710032, China.
- Regiment One of Cadets, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
ORCID-Profile: Dahai Hu
Förderung
- Key Project of the National Natural Science Foundation of China
- General Program of the National Natural Science Foundation of China
- Special Science Research Program for National Health and Public Welfare Industry in China
- National Natural Science Foundation of China
- Fourth Military Medical University
Zitieren
APA
Li, M., Dong, Y., Shang, Y., Liu, J., Wang, Y., Zhang, D., Zhang, L., Han, C., Zhang, Y., Shen, K., Yang, Y., Wang, H., Guan, H., & Hu, D. (2024). Metformin Syncs CeO 2 to Recover Intra‐ and Extra‐Cellular ROS Homeostasis in Diabetic Wound Healing. Small, 20(52). https://doi.org/10.1002/smll.202407802
Vancouver
Li M, Dong Y, Shang Y, Liu J, Wang Y, Zhang D, et al. Metformin Syncs CeO 2 to Recover Intra‐ and Extra‐Cellular ROS Homeostasis in Diabetic Wound Healing. Small. 2024;20(52). doi:10.1002/smll.202407802
BibTeX
@article{Li2024,
author = {Li, Mengyang and Dong, Yuhang and Shang, Yage and Liu, Jiaqi and Wang, Yunchuan and Zhang, Dongliang and Zhang, Lixia and Han, Chao and Zhang, Yue and Shen, Kuo and Yang, Yaoxiang and Wang, Hongtao and Guan, Hao and Hu, Dahai},
title = {Metformin Syncs CeO 2 to Recover Intra‐ and Extra‐Cellular ROS Homeostasis in Diabetic Wound Healing},
journal = {Small},
year = {2024},
volume = {20},
number = {52},
doi = {10.1002/smll.202407802}
}
EUVIMED